News

The Human Genome Project (HGP) and The SNP Consortium today announced plans to generate a new set of human DNA sequence information that will contribute 125,000 to 250,000 validated and useful genetic markers known as single nucleotide polymorphisms, or SNPs. The information also will enhance the HGP working draft sequence of the human genome.

The Human Genome Project public consortium today announced that it has assembled a working draft of the sequence of the human genome — the genetic blueprint for a human being. This major milestone involved two tasks: placing large fragments of DNA in the proper order to cover all of the human chromosomes, and determining the DNA sequence of these fragments.

The Whitehead Institute for Biomedical Research today announced a new program for Computational Biology, a scientific discipline regarded by researchers as critical to advancing gene research. The Computational Biology Fellows Program at the Whitehead Institute, with funding and scientific support from Pfizer Central Research, will begin with two Fellows, who will conduct independent research at the interface of biology, computer science, and mathematics.

In a promising new advance in vaccine development, scientists have identified a protein fragment that is exceptionally potent in eliciting an immune response against infected cells and cancer cells. When scientists injected a vaccine containing this fragment into mice lacking a healthy immune system, the animals were able to mount a cellular immune response despite their compromised immune system.

Of the 46 human chromosomes, 44 are members of identical pairs. But two—the X and the Y—stand apart because they have no perfect match. Nevertheless, evolution has charged these two genetic loners with the critical task of sex determination: embryos with two X chromosomes develop into females, while embryos with an X and a Y chromosome develop into males.

One of the biggest challenges in cancer treatment is choosing the right regimen for a given patient. Treatment strategies work differently for different tumors. In choosing effective treatments with minimal side effects, oncologists rely heavily on biopsy reports that diagnose the tumor type involved. However, even today, cancer diagnosis is done the old-fashioned way: by observing morphological changes in biopsies under the microscope. The method suffers from serious limitations because cancer cells that look similar under the microscope can follow different clinical courses and respond differently to therapy. Now, in a new study reported in Friday's Science,a team of Whitehead-led researchers reports the first systematic and objective approach for identifying and classifying tumor types.

Scientists have achieved a major step toward finding a new class of oral drugs to treat HIV infection. They have identified a class of compounds that prevent HIV infection by stopping the virus at its port of entry into the cell. Unlike currently used drugs that target HIV at other points during its life cycle — after it has already infected the cell — these compounds lock into a vulnerable "pocket" in the HIV's coat protein, preventing its fusion with cell membranes and thereby its ability to enter and infect cells.

Scientists at the Whitehead Institute for Biomedical Research and Millennium Pharmaceuticals, Inc. have identified a protein in the small intestine that plays a key role in the uptake of dietary fat into the body. The scientists report in the September 24 issue of Molecular Cell that the protein, called fatty acid transporter protein-4 (FATP4), may constitute a novel target for anti-obesity therapy in humans.

Researchers led by Dr. Robert A. Weinberg of the Whitehead Institute for Biomedical Research have made the first genetically defined human cancer cells, according to a report published in the July 29 issue of Nature. This achievement brings scientists one step closer to understanding the complex process by which human cells become cancerous.

Genetic studies at the Whitehead Institute for Biomedical Research have shown that some boys will be infertile as adults because they have inherited a genetic defect from their fathers through a commonly used method of assisted reproduction known as intracytoplasmic sperm injection (ICSI).